Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Who May Qualify: Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin. The patients included may be adults or children, and will be: - Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others), - Patients with systemic autoimmune conditions (where your immune system attacks your own body)s associated with skin damage (lupus, scleroderma, dermatomyositis for example), - Patients with cutaneous lupus - Patients with dysimmune skin diseases (psoriasis, eczema) - Patients with immuno-induced dermatological disorders or drug dermatitis - Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.). Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected Who Should NOT Join This Trial: - Patients under protective supervision (guardianship, curators) - Patients under 6 years old - Pregnant or breastfeeding woman Always talk to your doctor about whether this trial is right for you.